Brian Cooper

1.2k total citations
40 papers, 945 citations indexed

About

Brian Cooper is a scholar working on Epidemiology, Infectious Diseases and Radiation. According to data from OpenAlex, Brian Cooper has authored 40 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Radiation. Recurrent topics in Brian Cooper's work include Hepatitis B Virus Studies (6 papers), Nuclear Physics and Applications (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Brian Cooper is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Nuclear Physics and Applications (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Brian Cooper collaborates with scholars based in United States, United Kingdom and Switzerland. Brian Cooper's co-authors include Richard Quintiliani, C H Nightingale, Robert E. Levitz, Charles D. Goodwin, Simeón Margolis, Laurie L. Briceland, Jeffrey J. Stoddard, Lisa DeTora, Collin D. Freeman and Richard C. Tilton and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Brian Cooper

39 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Cooper United States	17	496	217	190	134	109	40	945
I. M. Hoepelman Netherlands	24	698 1.4×	307 1.4×	219 1.2×	47 0.4×	54 0.5×	66	1.4k
Ralph H. Raasch United States	18	368 0.7×	538 2.5×	91 0.5×	98 0.7×	46 0.4×	42	1.2k
Thomas R. Beam United States	17	401 0.8×	167 0.8×	247 1.3×	39 0.3×	43 0.4×	45	869
R. Garraffo France	19	313 0.6×	555 2.6×	340 1.8×	95 0.7×	53 0.5×	92	1.3k
Ernesto G. Scerpella United States	16	476 1.0×	527 2.4×	153 0.8×	58 0.4×	32 0.3×	28	1.1k
Hae Suk Cheong South Korea	18	430 0.9×	289 1.3×	113 0.6×	65 0.5×	134 1.2×	52	1.0k
Marisa Holubar United States	19	381 0.8×	569 2.6×	219 1.2×	140 1.0×	44 0.4×	74	1.2k
Dante Bassetti Italy	20	379 0.8×	647 3.0×	132 0.7×	87 0.6×	26 0.2×	72	1.3k
Hyun Kyun Ki South Korea	17	482 1.0×	243 1.1×	117 0.6×	56 0.4×	29 0.3×	45	1.0k
Michelle Brown United States	17	393 0.8×	319 1.5×	212 1.1×	62 0.5×	45 0.4×	48	982

Countries citing papers authored by Brian Cooper

Since Specialization

Citations

This map shows the geographic impact of Brian Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Cooper more than expected).

Fields of papers citing papers by Brian Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Cooper. The network helps show where Brian Cooper may publish in the future.

Co-authorship network of co-authors of Brian Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Cooper. A scholar is included among the top collaborators of Brian Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Cooper. Brian Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arling, Greg, et al.. (2021). A Data Driven Approach for Prioritizing COVID-19 Vaccinations in the Midwestern United States. Online Journal of Public Health Informatics. 13(1). e5–e5. 4 indexed citations

Cooper, Brian, et al.. (2020). Analyzing COVID-19 Mortality Within the Chicagoland Area. Figshare. 1 indexed citations

Kober, Kord M., et al.. (2015). (269) Variations in opioid receptor genes are associated with breast pain in women prior to and with mild and severe persistent breast pain after breast cancer surgery. Journal of Pain. 16(4). S43–S43.

Staplin, Natalie, Jonathan Emberson, Colin Baigent, et al.. (2014). CANCER AND CHRONIC KIDNEY DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 33,618 PARTICIPANTS. Oxford University Research Archive (ORA) (University of Oxford). 3 indexed citations

Shaw, Christine A., et al.. (2013). The path to an RSV vaccine. Current Opinion in Virology. 3(3). 332–342. 36 indexed citations

Bellinger, Steven L., et al.. (2012). Very large area multi-element microstructured semiconductor neutron detector panel array. Zenodo (CERN European Organization for Nuclear Research). 215–218. 4 indexed citations

Chaves, Sandra S., et al.. (2011). Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection. Vaccine. 29(52). 9618–9623. 36 indexed citations

Cooper, Brian, Lisa DeTora, & Jeffrey J. Stoddard. (2010). Menveo^®: a novel quadrivalent meningococcal CRM₁₉₇conjugate vaccine against serogroups A, C, W-135 and Y. Expert Review of Vaccines. 10(1). 21–33. 50 indexed citations

Overmoyer, Beth, Kelly M. Robertson, Jesse M. Lewin, et al.. (2001). A phase I pharmacokinetic and pharmacodynamic study of SU5416 and Adriamycin in inflammatory breast cancer. Breast Cancer Research and Treatment. 69(3). 13 indexed citations

10.

Dieckhaus, Kevin D. & Brian Cooper. (1998). INFECTION CONTROL CONCEPTS IN CRITICAL CARE. Critical Care Clinics. 14(1). 55–70. 13 indexed citations

11.

Nicolau, David P., Markos Marangos, C H Nightingale, et al.. (1996). Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis. Antimicrobial Agents and Chemotherapy. 40(1). 55–60. 12 indexed citations

12.

Levitz, Robert E., et al.. (1995). Immunization with High-Dose Intradermal Recombinant Hepatitis B Vaccinein Healthcare Workers Who Failed to Respond to Intramuscular Vaccination. Infection Control and Hospital Epidemiology. 16(2). 88–91. 23 indexed citations

13.

Cooper, Brian, et al.. (1992). Seroprevalence of Antibodies to Hepatitis C Virus in High-Risk Hospital Personnel. Infection Control and Hospital Epidemiology. 13(2). 82–85. 43 indexed citations

14.

Maderazo, Eufronio G., et al.. (1990). Aspergillus Endocarditis: Cure Without Surgical Valve Replacement. Southern Medical Journal. 83(3). 351–352. 7 indexed citations

15.

Cooper, Brian, et al.. (1989). Pneumococcal bacteremia during Ciprofloxacin therapy for pneumococcal pneumonia. The American Journal of Medicine. 87(4). 475–475. 63 indexed citations

16.

Cooper, Brian. (1989). Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.. PubMed. 15(7). 9–15. 2 indexed citations

17.

Wansbrough‐Jones, Mark, et al.. (1988). Prophylaxis against B virus infection.. BMJ. 297(6653). 909–909. 3 indexed citations

18.

Nightingale, Charles H., et al.. (1988). The conversion of cefoxitin usage to cefotetan: An interdisciplinary approach. The American Journal of Surgery. 155(5). 101–102. 3 indexed citations

19.

Quintiliani, Richard, Brian Cooper, Laurie L. Briceland, & C H Nightingale. (1987). Economic impact of streamlining antibiotic administration.. PubMed. 82(4A). 391–4. 90 indexed citations

20.

Cooper, Brian, et al.. (1986). Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients. American Journal of Infection Control. 14(5). 204–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact